http://www.unboundmedicine.com/medline/ebm/research/busulfanUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19891548/full_citation/Can_the_pharmacogenetics_of_GST_gene_polymorphisms_predict_the_dose_of_busulfan_in_pediatric_hematopoietic_stem_cell_transplantationAnsari M, Krajinovic M 
Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation? [Editorial, Research Support, Non-U.S. Gov't]
Pharmacogenomics 2009 Nov; 10(11):1729-32.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19890786/full_citation/Allogeneic_Stem_Cell_Transplantation_for_Pediatric_and_Adolescent_Patients_with_CML:_Results_from_the_Prospective_Trial_CML_paed_I_Suttorp M, Claviez A, Bader P, et al. 
Allogeneic Stem Cell Transplantation for Pediatric and Adolescent Patients with CML: Results from the Prospective Trial CML-paed I. [JOURNAL ARTICLE]
Klin Padiatr 2009 Nov; 221(6):351-357.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19852270/full_citation/[Establishment_of_recipient_mouse_model_of_stem_cell_transplantation_into_testicular_seminiferous_tubules_and_improvement_of_transplantation_techniques]Zhang W, Xia XY, Ding H, et al. 
[Establishment of recipient mouse model of stem cell transplantation into testicular seminiferous tubules and improvement of transplantation techniques] [English Abstract, Journal Article]
Zhonghua Nan Ke Xue 2009 Aug; 15(8):703-7.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19849809/full_citation/Successful_unrelated_donor_cord_blood_transplantation_for_Glanzmann's_thrombasthenia_Kitko CL, Levine JE, Matthews DC, et al. 
Successful unrelated donor cord blood transplantation for Glanzmann's thrombasthenia. [JOURNAL ARTICLE]
Pediatr Transplant 2009 Oct 22.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19822305/full_citation/Busulfan_and_cyclophosphamide__bu/cy__as_a_preparative_regimen_for_autologous_stem_cell_transplantation_in_patients_with_non_hodgkin_lymphoma:_a_single_institution_experience_Ulrickson M, Aldridge J, Kim HT, et al. 
Busulfan and cyclophosphamide (bu/cy) as a preparative regimen for autologous stem cell transplantation in patients with non-hodgkin lymphoma: a single-institution experience. [Journal Article]
Biol Blood Marrow Transplant 2009 Nov; 15(11):1447-54.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19822304/full_citation/Early_and_late_neurological_complications_after_reduced_intensity_conditioning_allogeneic_stem_cell_transplantation_Barba P, Piñana JL, Valcárcel D, et al. 
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation. [Journal Article]
Biol Blood Marrow Transplant 2009 Nov; 15(11):1439-46.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19822302/full_citation/Improved_nonrelapse_mortality_and_infection_rate_with_lower_dose_of_antithymocyte_globulin_in_patients_undergoing_reduced_intensity_conditioning_allogeneic_transplantation_for_hematologic_malignancies_Hamadani M, Blum W, Phillips G, et al. 
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies. [Journal Article]
Biol Blood Marrow Transplant 2009 Nov; 15(11):1422-30.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19821828/full_citation/Superior_survival_after_replacing_oral_with_intravenous_busulfan_in_autologous_stem_cell_transplantation_for_non_Hodgkin_lymphoma_with_busulfan_cyclophosphamide_and_etoposide_Dean RM, Pohlman B, Sweetenham JW, et al. 
Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide. [JOURNAL ARTICLE]
Br J Haematol 2009 Oct 11.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19821825/full_citation/Incidence_and_reasons_for_late_failure_after_allogeneic_haematopoietic_cell_transplantation_following_BuCy2_in_acute_myeloid_leukaemia_Pant S, Hamadani M, Dodds AJ, et al. 
Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia. [JOURNAL ARTICLE]
Br J Haematol 2009 Oct 11.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19821799/full_citation/Patterns_and_kinetics_of_T_cell_chimerism_after_allo_transplant_with_alemtuzumab_based_conditioning:_mixed_chimerism_protects_from_GVHD_but_does_not_portend_disease_recurrence_van Besien K, Dew A, Lin S, et al. 
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence. [JOURNAL ARTICLE]
Leuk Lymphoma 2009 Oct 3.
Abstract | Full Citation | Find Related Articles